TGFβ/Smad signaling system and its pathologic correlates
- 30 August 2002
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 116A (1) , 1-10
- https://doi.org/10.1002/ajmg.a.10750
Abstract
No abstract availableThis publication has 103 references indexed in Scilit:
- Polymorphism R25P in the gene encoding transforming growth factor‐beta (TGF‐β1) is a newly identified risk factor for proliferative diabetic retinopathyAmerican Journal of Medical Genetics, 2002
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Smad5 Is Essential for Left–Right Asymmetry in MiceDevelopmental Biology, 2000
- Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory responseNature Cell Biology, 1999
- Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by SmadsDevelopment, 1997
- Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated SignalingPublished by Elsevier ,1997
- Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood PressureHypertension, 1996
- Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.Proceedings of the National Academy of Sciences, 1995
- Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast CancerNew England Journal of Medicine, 1993
- Evolutionary Origins of the Transforming Growth Factor-β Gene FamilyDNA and Cell Biology, 1992